Idelalisib for Relapsed Follicular Lymphoma (FL) and Small Lymphocytic Leukemia (SLL) Voluntarily Withdrawn from US Market
This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
My friends at Bloodwise, a UK based blood cancer charity, have made this short video aimed specifically at all patients with blood cancer concerning coronavirus.
While their resources are mostly there to assist those in the United Kingdom, their video is helpful to any CLL/SLL patients regardless of where they live.
Bloodwise’s Chief Executive Gemma Peters is correct when she includes chronic leukemia and lymphoma, treated or not, as putting those patients at higher risk for more serious disease due to suppressed immunity.
To be clear, that includes all us CLL and SLL patients, whether we are in watch or wait or in a deep remission post treatment. We are all immune compromised to some greater or lesser extent and Gemma offers sensible advise in this YouTube video.
Related posts